Search This Blog

Friday, September 28, 2018

Corcept granted orphan status for pancreatic cancer treatment


The FDA granted Corcept Therapeutics orphan status for relacorilant, its treatment of pancreatic cancer
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)